Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Research output: Contribution to journalComment/debate

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)773; author reply 773-774
JournalNeurology
Volume72
Issue number8
StatePublished - Feb 24 2009

ASJC Scopus subject areas

  • Clinical Neurology

Cite this